Evidence map›Paper›PMID 32994235›Full record

ArticleBMJ open2020

Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: translating evidence into practice.

Raquel Varas-Doval, Miguel A Gastelurrutia, Shalom I Benrimoj, Maria Jose Zarzuelo, Victoria Garcia-Cardenas, Beatriz Perez-Escamilla, Fernando Martínez-Martínez

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05348538 (Feasibility Study of the Medication Review With Follow up Service for Patients With Polypharmacy in Swiss Community Pharmacies), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05348538 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Feasibility Study of the Medication Review With Follow up Service for Patients With Polypharmacy in Swiss Community Pharmacies

TypeinterventionalSponsorCenter for Primary Care and Public Health (Unisante), University of Lausanne, SwitzerlandRan2023 to 2024Enrolled162ConditionsChronic DiseaseArmsMedication review with follow up or MaJ? for the acronym in french
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. ReflACTION framework: A proposed model for implementation of clinical pharmacy services.Exploratory research in clinical and social pharmacy · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raquel Varas-DovalDepartment of Pharmaceutical Services, Spanish General Council of Official Colleges of Pharmacists, Madrid, Spain.ORCID 0000-0002-0666-9739
Miguel A GastelurrutiaPharmaceutical Care Research Group, CTS-131, University of Granada Faculty of Pharmacy, Granada, Spain magastelu@farmanorte.org.ORCID 0000-0003-1019-0234
Shalom I BenrimojPharmaceutical Care Research Group, CTS-131, University of Granada Faculty of Pharmacy, Granada, Spain.ORCID 0000-0001-9768-7838
Maria Jose ZarzueloPharmaceutical Care Research Group, CTS-131, University of Granada Faculty of Pharmacy, Granada, Spain.ORCID 0000-0001-8635-8094
Victoria Garcia-CardenasGraduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-3770-4557
Beatriz Perez-EscamillaPharmaceutical Care Research Group, CTS-131, University of Granada Faculty of Pharmacy, Granada, Spain.ORCID 0000-0002-3209-3147
Fernando Martínez-MartínezClinical Pharmacy Section, Pharmacy Department, Universidad de Granada, Granada, Spain.ORCID 0000-0001-8247-1751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate an implementation programme of a community pharmacy medication review with follow-up (MRF) service using a hybrid effectiveness-implementation study design, and to compare the clinical and humanistic outcomes with those in a previously conducted cluster randomised controlled trial (cRCT).

settingCommunity pharmacies in Spain.

participants135 community pharmacies and 222 pharmacists providing MRF to polymedicated patients aged 65 or over.

interventionThe intervention was an implementation programme for the MRF service. A national level group was established, mirrored with a provincial level group. A series of interventions were defined (1) to engage pharmacy owners with the implementation model and (2) to provide training to pharmacists consisting of clinical case studies, process of MRF, communication skills and data collection methods and (3) practice change facilitators. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcomes for the implementation programme were progress, reach, fidelity and integration. The secondary outcomes were number of medications, non-controlled health problems, emergency visits, hospitalisations and health-related quality of life, which were compared with a previous 6-month cluster RCT.

results55% of pharmacies reached the implementation phase and 35.6% remained in the testing phase at 12 months. A reach of 89.3% (n=844) was achieved. Fidelity average score was 8.45 (min: 6.2, max: 9.3) out of 10. The integration mean score was 3.39 (SD: 0.72) out of 5. MRF service outcomes were similar to the cluster RCT study; however, the magnitude of the outcomes was delayed.

conclusionsThe implementation of pharmacy services is a complex multifactorial process, conditioned by numerous implementation factors. In the absence of remuneration, the implementation of the MRF service is a slow process, taking at least 12 months to complete. TRIAL REGISTRATION NUMBER: CGFTRA-2017-01.

Indexed as

Community Pharmacy ServicesPharmaciesAgedFollow-Up StudiesHumansQuality of LifeSpainchange managementhealth services administration & managementprimary carepublic health

Identifiers

PMID32994235
PMCPMC7526286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.